1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort
(
- Contribution to journal › Article
-
Mark
The Leydig cell biomarker INSL3 as a predictor of age-related morbidity : Findings from the EMAS cohort
(
- Contribution to journal › Article
-
Mark
Reproductive hormone levels, androgen receptor CAG repeat length and their longitudinal relationships with decline in cognitive subdomains in men : The European Male Ageing Study.
(
- Contribution to journal › Article
- 2021
-
Mark
Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)
(
- Contribution to journal › Article
- 2018
-
Mark
Reproductive hormone levels predict changes in frailty status in community-dwelling older men : European male ageing study prospective data
(
- Contribution to journal › Article
-
Mark
Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism : Prospective results from the EMAS
(
- Contribution to journal › Article
-
Mark
Elevated luteinizing hormone despite normal testosterone levels in older men-natural history, risk factors and clinical features
(
- Contribution to journal › Article
- 2017
-
Mark
Nonandrogenic anabolic hormones predict risk of frailty : European male ageing study prospective data
(
- Contribution to journal › Article
-
Mark
Frailty and bone health in European men
(
- Contribution to journal › Article
- 2016
-
Mark
Worldwide trends in diabetes since 1980 : A pooled analysis of 751 population-based studies with 4.4 million participants
(
- Contribution to journal › Article